Search Within

Brian Kushner

  1. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. GSK Faculty (6)
  4. Hematologic Malignancies Research (6)
  5. Neuroblastoma Service (6)
  6. Pediatrics, Department of (6)

More Groups

People
  1. Nai-Kong Cheung (5)
  2. Shakeel Modak (5)
  3. Stephen Roberts (5)
  4. Katharine Hsu (4)
  5. Kim Kramer (4)
  6. Ellen Basu (3)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2012 (2)
  5. 2010 (1)
Publications
  1. Pediatric Blood and Cancer (2)
  2. Cancer Research (1)
  3. Cold Spring Harbor Molecular Case Studies (1)
  4. Journal of Immunotherapy (1)
  5. OncoImmunology (1)
Publishers
  1. Wiley Periodicals, Inc (2)
  2. American Association for Cancer Research (1)
  3. Cold Spring Harbor Laboratory Press (1)
  4. Landes Bioscience (1)
  5. Lippincott Williams & Wilkins (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care
    Journal Article

    Walsh, M. F.; Kennedy, J.; Harlan, M.; Kentsis, A.; Shukla, N.; Musinsky, J.; Roberts, S.; Kung, A. L.; Robson, M.; Kushner, B. H.; more...
    Cold Spring Harbor Molecular Case Studies (2017)

    Fulltext@MSK | Save
  • Germline mutations in cancer predisposition genes in a subset of pediatric oncology patients undergoing targeted solid tumor sequencing using matched normal DNA
    Meeting Abstract

    Walsh, M.; Shukla, N.; Joseph, V.; Kentsis, A.; Curran, K.; Kobos, R.; Arnold, A.; Harlan, M.; Kennedy, J.; Schrader, K.; more...
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S.; Gallagher, M.; Hsu, K.
    Journal of Immunotherapy (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save